Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A phyllodes tumor of the breast characterized by infiltrative margins and a sarcomatous stromal component. The sarcomatous stroma usually displays features of fibrosarcoma. Liposarcomatous, osteosarcomatous, or rhabdomyosarcomatous elements may also be present.
Biomarker and diagnostic research for malignant breast phyllodes tumor has been reported in the published literature.
2 clinical trials registered. Interventions under study include other interventions and gene therapy. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.
253 publications have been identified in PubMed for malignant breast phyllodes tumor. Research spans Case Report / Case Series (42%), Epidemiology / Natural History (13%), and Review / Meta-Analysis (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 105 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:54 AM UTC
Disease patterns and progression | 34 | 13% |
Research summaries | 30 | 12% |
Laboratory research | 29 | 11% |
Testing and diagnosis research | 28 | 11% |
Clinical study results | 21 | 8% |
Other research | 3 | 1% |
New treatment approaches | 3 | 1% |
Pang JB (2026). [PMID: 41611646](https://pubmed.ncbi.nlm.nih.gov/41611646/). *Histopathology*. [Epidemiology / Natural History]
Temuroğlu A (2026). [PMID: 41710015](https://pubmed.ncbi.nlm.nih.gov/41710015/). *Front Pediatr*. [Case Report / Case Series]
Langade Y (2026). [PMID: 42236687](https://pubmed.ncbi.nlm.nih.gov/42236687/). *Ann Afr Med*. [Case Report / Case Series]
Tsukiyama E (2026). [PMID: 42078310](https://pubmed.ncbi.nlm.nih.gov/42078310/). *Cancer Diagn Progn*. [Epidemiology / Natural History]
Rakha EA (2026). [PMID: 41285251](https://pubmed.ncbi.nlm.nih.gov/41285251/). *Mod Pathol*. [Review / Meta-Analysis]
Okumura A (2026). [PMID: 41204772](https://pubmed.ncbi.nlm.nih.gov/41204772/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Apornvirat S (2026). [PMID: 41856559](https://pubmed.ncbi.nlm.nih.gov/41856559/). *J Clin Pathol*. [Diagnostic / Biomarker]
Yuan J (2026). [PMID: 42109654](https://pubmed.ncbi.nlm.nih.gov/42109654/). *Front Oncol*. [Case Report / Case Series]
Wang XR (2026). [PMID: 41924605](https://pubmed.ncbi.nlm.nih.gov/41924605/). *Front Oncol*. [Case Report / Case Series]
Shao Y (2026). [PMID: 41492112](https://pubmed.ncbi.nlm.nih.gov/41492112/). *Ann Surg Oncol*. [Basic Science / Preclinical]
AI-curated news mentioning malignant breast phyllodes tumor
Updated Aug 4, 2026
A recent study highlights the competing risks of cardiovascular and tumor-specific mortality in patients with malignant phyllodes tumor. This research underscores the need for comprehensive management strategies in this rare tumor type.
A recent study highlights the diagnostic challenges posed by primary inflammatory myofibroblastic tumors of the breast during aspiration cytology. This research underscores the need for heightened awareness among pathologists to avoid misdiagnosis.